Medical Innovations Need Science and Capital ft. Kyle Rasbach, PhD, PharmD and Blake Schwarz, DMin Invest by Design

In this episode, Shaun Morgan interviews Dr. Kyle Rasbach to discuss how a background in science and medicine can give investors a distinct advantage when investing in biotechnology companies. We also hear a personal story of the dramatic impact that investing has on real lives.Follow Eventide on LinkedIn, Subscribe to our Insights, and learn about our approach at eventideinvestments.com. This podcast is for informational purposes only and expresses the views of the speaker an...